(Adds: Revance Therapeutics, Enterprise Bancorp, Novolex, Arthur J Gallagher, Dow Updates: Omnicom Group)

Dec 9 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1430 GMT on Monday:

** Anti-wrinkle injection maker Revance Therapeutics

has agreed to be bought for $3.10 per share by privately held Crown Laboratories, instead of the $6.66 per share agreed previously, the two companies said.

** Enterprise Bancorp and Independent Bank

, the parent of Rockland Trust, have agreed to merge in a cash-and-stock deal valued at $562 million, they said, as regional lenders continue to consolidate their operations.

** Apollo Global Management-owned Novolex will buy packaging products maker Pactiv Evergreen in a $6.7 billion deal, the companies said.

** Arthur J Gallagher said it would acquire insurance broker AssuredPartners in an all-cash deal worth $13.45 billion, as it looks to bolster its focus on property and casualty and employee benefits across the U.S.

** Omnicom Group has struck a $13.25 billion all-stock deal to buy rival Interpublic Group , creating the world's largest advertising agency as traditional players look to better compete with Big Tech firms amid accelerating use of AI.

** Dow said it would sell a 40% stake in some U.S. Gulf Coast infrastructure assets to a fund managed by Macquarie Asset Management for $2.4 billion as it looks to focus more on its core chemicals business.

** Nature Infrastructure Capital and Davidson Kempner Capital Management said that they had jointly acquired the Dutch-based solar power and storage project development platform of Greencells Group.

(Compiled by Rajarshi Roy and Kamal Choudhury in Bengaluru)

((Rajarshi.Roy@thomsonreuters.com;))